296 related articles for article (PubMed ID: 26635427)
1. Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination.
Angeletti S; Dicuonzo G; Fioravanti M; De Cesaris M; Fogolari M; Lo Presti A; Ciccozzi M; De Florio L
Dis Markers; 2015; 2015():951532. PubMed ID: 26635427
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.
Angeletti S; Spoto S; Fogolari M; Cortigiani M; Fioravanti M; De Florio L; Curcio B; Cavalieri D; Costantino S; Dicuonzo G
APMIS; 2015 Sep; 123(9):740-8. PubMed ID: 26058482
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis.
Angeletti S; Battistoni F; Fioravanti M; Bernardini S; Dicuonzo G
Clin Chem Lab Med; 2013 May; 51(5):1059-67. PubMed ID: 23072859
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin and MR-Proadrenomedullin Combination with SOFA and qSOFA Scores for Sepsis Diagnosis and Prognosis: A Diagnostic Algorithm.
Spoto S; Cella E; de Cesaris M; Locorriere L; Mazzaroppi S; Nobile E; Lanotte AM; Pedicino L; Fogolari M; Costantino S; Dicuonzo G; Ciccozzi M; Angeletti S
Shock; 2018 Jul; 50(1):44-52. PubMed ID: 29023361
[TBL] [Abstract][Full Text] [Related]
5. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
[TBL] [Abstract][Full Text] [Related]
7. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.
Travaglino F; De Berardinis B; Magrini L; Bongiovanni C; Candelli M; Silveri NG; Legramante J; Galante A; Salerno G; Cardelli P; Di Somma S
BMC Infect Dis; 2012 Aug; 12():184. PubMed ID: 22874067
[TBL] [Abstract][Full Text] [Related]
8. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
[TBL] [Abstract][Full Text] [Related]
9. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.
Elke G; Bloos F; Wilson DC; Brunkhorst FM; Briegel J; Reinhart K; Loeffler M; Kluge S; Nierhaus A; Jaschinski U; Moerer O; Weyland A; Meybohm P;
Crit Care; 2018 Mar; 22(1):79. PubMed ID: 29562917
[TBL] [Abstract][Full Text] [Related]
10. Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points.
Oberhoffer M; Russwurm S; Bredle D; Chatzinicolaou K; Reinhart K
Intensive Care Med; 2000 Mar; 26 Suppl 2():S170-4. PubMed ID: 18470714
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin and MR-proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock.
Spoto S; Fogolari M; De Florio L; Minieri M; Vicino G; Legramante J; Lia MS; Terrinoni A; Caputo D; Costantino S; Bernardini S; Ciccozzi M; Angeletti S
Microb Pathog; 2019 Dec; 137():103763. PubMed ID: 31574301
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
Zhao Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
[TBL] [Abstract][Full Text] [Related]
13. MR-proADM: A New Biomarker for Early Diagnosis of Sepsis in Burned Patients.
Gille J; Ostermann H; Dragu A; Sablotzki A
J Burn Care Res; 2017; 38(5):290-298. PubMed ID: 28221298
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
Bernal-Morell E; García-Villalba E; Vera MDC; Medina B; Martinez M; Callejo V; Valero S; Cinesi C; Piñera P; Alcaraz A; Marin I; Muñoz A; Cano A
J Infect; 2018 Mar; 76(3):249-257. PubMed ID: 29246637
[TBL] [Abstract][Full Text] [Related]
15. MR- proADM to detect specific types of organ failure in infection.
Andrés C; Andaluz-Ojeda D; Cicuendez R; Nogales L; Martín S; Martin-Fernandez M; Almansa R; Calvo D; Esteban-Velasco MC; Vaquero-Roncero LM; Ríos-Llorente A; Sanchez-Barrado E; Muñoz-Bellvís L; Aldecoa C; Bermejo-Martin JF
Eur J Clin Invest; 2020 Jun; 50(6):e13246. PubMed ID: 32307701
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
[TBL] [Abstract][Full Text] [Related]
17. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis.
Riché FC; Cholley BP; Laisné MJ; Vicaut E; Panis YH; Lajeunie EJ; Boudiaf M; Valleur PD
Surgery; 2003 Mar; 133(3):257-62. PubMed ID: 12660636
[TBL] [Abstract][Full Text] [Related]
19. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of procalcitonin and mid-regional pro-adrenomedullin in septic paediatric patients.
Solé-Ribalta A; Bobillo-Pérez S; Valls A; Girona-Alarcón M; Launes C; Cambra FJ; Jordan I; Esteban E
Eur J Pediatr; 2020 Jul; 179(7):1089-1096. PubMed ID: 31974673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
